Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Astria Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +5 vs. Q2 2024
- Shares held
- 56.5M
- +4.50M (+8.6%) vs. Q2 2024
- Total value
- $622.1M
- +$148.7M (+31.4%) vs. Q2 2024
- New holders
- 16
- 33 more added
- Sold out
- 11
- 37 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 5,105,213 | $56.2M | 0.65% | +61,457+1.2% | Added |
| Perceptive Advisors LLC | 6,485,420 | $71.4M | 1.53% | 00.0% | Unchanged |
| FMR LLC | 7,822,275 | $86.1M | 0.01% | +1,767,714+29.2% | Added |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −281,410−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −201,210−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −68,697−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −56,300−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −50,776−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −30,926−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −13,064−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −857−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −613−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −219−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |